After Hours Summary: JWN +10% (and lifting retail names) on potential privatization deal, CNC +2% higher on $3.75 bln acquisition newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to news: SNAK +26.6% (to sell its frozen business for $50 mln; strategic and financial review remains ongoing), SENS +13% (Senseonics received CE Mark approval for the Eversense XL Continuous Glucose Monitoring System), ZFGN +4.7% (ticking higher - announces initiation of ZAF-1061-201, the Co's Phase 2 clinical trial evaluating ZGN-1061 in patients with type 2 diabetes), AKCA +3.2% (Akcea Therapeutics and Ionis announce filing of New Drug Submission for Volanesorsen to Health Canada - an investigational medicine for the treatment of familial chylomicronemia syndrome), CNC +2.3% (Centene to acquire substantially all of the assets of Fidelis Care for $3.75 bln - will become Centene's health plan in New York State), TEX +2.1% (ticking higher; Marcato's McGuire discusses Terex position on Delivering Alpha), ARRY +1.9% (Point72 Asset Management increases passive stake to 5.4%), NCS +1.1% (Director purchased 30K shares on 9/11), MU +1% (upgraded at Goldman after the close), EOG +0.8% (upgraded to Overweight at Morgan Stanley)
Retail names higher with Nordstrom (JWN +10.3%) leading the way on PE speculation: M +2.7%, SHOS +1.2%, JCP +0.7%, etf - XRT +0.7%, DDS +4%, SHLD +1.3%After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: AMRK -10.9% (thinly traded), RLGT -6.4%
Companies trading lower in after hours in reaction to news: ITEK -9.5% (Inotek Pharmaceuticals to merge with US-based gene therapy company Rocket Pharmaceuticals - will host a conference call Sept 13 at 8:30am ET), TCMD -4.3% ( announces 2.7 mln share secondary offering by stockholders), AGNC -3.3% (to make public offering of 24,500,000 shares of common stock), CLDX -2.6% (announces the resignation of Chief Medical Officer Thomas Davis effective September 29 ), WLL -1.8% (downgraded to Underweight at Morgan Stanley), ON -1.7% (downgraded at Goldman after the close)